Nexstim Oyj: Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)

AI Briefing

• – Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)
• – Nexstim Plc announces that its NBS System 6 has received clearance from the US FDA
• – Nexstim's NBS System 6 is designed to treat OCD in patients